[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:systemic-amyloidosis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":30,"states":31},"Systemic amyloidosis",3,2,[8,16,23],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05758493","Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis",[12],"Phase 2","RECRUITING","2026-08-26T02:18:31.944757Z","2026-05-05T02:43:27.513821Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05951816","A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis",[20],"Phase 1","2026-08-26T02:15:49.658025Z","2026-07-30T01:46:14.440859Z",{"nct_id":24,"title":25,"phases":26,"status":27,"updated_at":28,"content_modified":29},"NCT05521022","Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis",[20],"UNKNOWN","2026-08-03T03:33:53.839199Z","2026-05-05T02:43:27.339473Z",[],[]]